# US 2010/0167400 A1 · Composition for Increasing Intracellular Nitric Oxide and Method for the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167400 A1
- Document ID: US20100167400A1
- Status: Published application
- Kind: A1
- Application number: 12/087,072
- Filed: 2007-01-01
- Published: 2010-07-01
- Earliest claimed: 2007-01-01
- Inventors: Ting-Kai Leung; Yuan-Soon Ho; Huey-Fang Shang; Yi-Hsuan Lee; Yung-Sheng Lin; Ming-Yu Lin; Jiann-Shiun Kao
- Web page: https://patentgrep.com/patent/US20100167400A1

## CPC

- A61K 41/0057: {Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent}
- A61K 41/17: by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A composition and a method for increasing intracellular nitric oxide is provided. The composition comprises a far-infrared ray releasing substance composed mainly of an oxide mineral for releasing a far-infrared ray, wherein the composition promotes generation of the nitric oxide via irradiation of the far-infrared ray from the far-infrared ray releasing substance. In another aspect, the method comprises setting an effective amount of a far-infrared ray releasing substance in a place close to a cell with an appropriate distance, and incubating the far-infrared ray releasing substance with the cell for a specific period, wherein the appropriate distance lies in an irradiation range of the far-infrared ray releasing substance.

## Claims

### Claim 1

A composition for increasing a nitric oxide in a cell, comprising:
a far-infrared ray releasing substance composed mainly of an oxide mineral for releasing a far-infrared ray;
wherein the composition promotes a generation of the nitric oxide via an irradiation of the far-infrared ray from the far-infrared ray releasing substance.

### Claim 2 (depends on 1)

The composition as claimed in claim 1, wherein the cell is one selected from a group consisting of a cancer cell, a neural cell, an endothelium cell and an antigen presenting cell.

### Claim 3 (depends on 1)

The composition as claimed in claim 1, wherein the far-infrared ray releasing substance is in a form selected from a group consisting of a bulk solid, a grain, a powder and a membrane, and releases the far-infrared ray under a room temperature.

### Claim 4 (depends on 1)

The composition as claimed in claim 1, wherein the oxide mineral is an aluminum oxide.

### Claim 5 (depends on 4)

The composition as claimed in claim 4, wherein the aluminum oxide is 60-95% in weight.

### Claim 6

A pharmaceutical composition for increasing a nitric oxide, comprising:
a pharmaceutically effective amount of a-far infrared ray releasing substance;
wherein the pharmaceutical composition promotes a generation of the nitric oxide via an irradiation of the far-infrared ray releasing substance.

### Claim 7 (depends on 6)

The pharmaceutical composition as claimed in claim 6 being used for improving a nitric oxide-defective disease.

### Claim 8 (depends on 6)

The pharmaceutical composition as claimed in claim 6, wherein the pharmaceutically effective amount of the far-infrared ray releasing substance increases the nitric oxide generation in a cell.

### Claim 9 (depends on 8)

The pharmaceutical composition as claimed in claim 8, wherein the cell is one selected from a group consisting of a cancer cell, a neural cell, an endothelium cell and an antigen presenting cell.

### Claim 10 (depends on 6)

The pharmaceutical composition as claimed in claim 6, wherein the pharmaceutically effective amount of the far-infrared ray releasing substance is in a form selected from a group consisting of a bulk solid, a grain, a powder and a membrane, and releases the far-infrared ray under a room temperature.

### Claim 11 (depends on 6)

The pharmaceutical composition as claimed in claim 6, wherein the far-infrared ray releasing substance is composed mainly of an oxide mineral, and the oxide mineral is an aluminum oxide.

### Claim 12 (depends on 11)

The pharmaceutical composition as claimed in claim 11, wherein the aluminum oxide is 60-95% in weight.

### Claim 13

A method for increasing a nitric oxide, comprising:
setting an effective amount of a far-infrared ray releasing substance in a place close to a cell with an appropriate distance, wherein the appropriate distance lies in an irradiation range of the far-infrared ray releasing substance; and
incubating the far-infrared ray releasing substance with the cell for a specific period.

### Claim 14 (depends on 13)

The method as claimed in claim 13, wherein the effective amount of the far-infrared ray releasing substance is composed mainly of an oxide mineral.

### Claim 15 (depends on 14)

The method as claimed in claim 14, wherein the oxide mineral is an aluminum oxide.

### Claim 16 (depends on 15)

The method as claimed in claim 15, wherein the aluminum oxide is 60-95% in weight.

### Claim 17 (depends on 13)

The method as claimed in claim 13, wherein the effective amount of the far-infrared ray releasing substance increases the nitric oxide generation in a cell without directly contacting with the cell.

### Claim 18 (depends on 13)

The method as claimed in claim 13, wherein the cell is one selected from a group consisting of a cancer cell, a neural cell, an endothelium cell and an antigen presenting cell.

### Claim 19 (depends on 13)

The method as claimed in claim 13, wherein the pharmaceutically effective amount of the far-infrared ray releasing substance is in a form selected from a group consisting of a bulk solid, a grain, a powder and a membrane, and releases the far-infrared ray under a room temperature.

### Claim 20 (depends on 13)

The method as claimed in claim 13, wherein the specific period is 10-60 minutes.
